Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manu V Chakravarthy

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
The Journal of Physiology|July 12, 2008
Cessation of daily exercise dramatically alters precursors of hepatic steatosis in Otsuka Long-Evans Tokushima Fatty (OLETF) ratsR Scott Rector, John P Thyfault, Matthew J Laye, et al.
Clinical and Translational Gastroenterology|September 21, 2020
Safety, Tolerability, and Physiological Effects of AXA1665, a Novel Composition of Amino Acids, in Subjects With Child-Pugh A and B CirrhosisManu V Chakravarthy, Joel Neutel, Scharmen Confer, et al.
Cell Metabolism|December 7, 2007
Respiratory uncoupling in skeletal muscle delays death and diminishes age-related diseaseAllison C Gates, Carlos Bernal-Mizrachi, Sharon L Chinault, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 1, 2015
Quantification, Variability, and Reproducibility of Basal Skeletal Muscle Glucose Uptake in Healthy Humans Using 18F-FDG PET/CTOlivier Gheysens, Andrey Postnov, Christophe M Deroose, et al.
Frontiers in Nutrition|July 30, 2019
A Novel Amino Acid Composition Ameliorates Short-Term Muscle Disuse Atrophy in Healthy Young MenTanya M Holloway, Chris McGlory, Sean McKellar, et al.
Diabetes, Obesity & Metabolism|August 5, 2025
Efficacy and safety of CT-868, a novel, fully biased, dual glucagon-like peptide-1/glucose-dependent insulinotropic polypeptide receptor agonist, in type 2 diabetes: A double-blind, randomized placebo controlled phase 2 trialManu V Chakravarthy, Michael A Elliott, Luis Acosta, et al.
Cell Reports. Medicine|June 3, 2025
Biased agonism of GLP-1R and GIPR enhances glucose lowering and weight loss, with dual GLP-1R/GIPR biased agonism yielding greater efficacyRuben Rodriguez, Anne Hergarden, Shyam Krishnan, et al.
Molecular Metabolism|November 30, 2025
Effects of CT-388, a once-weekly signaling-biased dual GLP-1/GIP receptor agonist, on weight loss and glycemic control in preclinical models and participants with obesityManu V Chakravarthy, Ruben Rodriguez, Anne Hergarden, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
The Journal of Physiology|July 12, 2008
Cessation of daily exercise dramatically alters precursors of hepatic steatosis in Otsuka Long-Evans Tokushima Fatty (OLETF) ratsR Scott Rector, John P Thyfault, Matthew J Laye, et al.
Clinical and Translational Gastroenterology|September 21, 2020
Safety, Tolerability, and Physiological Effects of AXA1665, a Novel Composition of Amino Acids, in Subjects With Child-Pugh A and B CirrhosisManu V Chakravarthy, Joel Neutel, Scharmen Confer, et al.
Cell Metabolism|December 7, 2007
Respiratory uncoupling in skeletal muscle delays death and diminishes age-related diseaseAllison C Gates, Carlos Bernal-Mizrachi, Sharon L Chinault, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 1, 2015
Quantification, Variability, and Reproducibility of Basal Skeletal Muscle Glucose Uptake in Healthy Humans Using 18F-FDG PET/CTOlivier Gheysens, Andrey Postnov, Christophe M Deroose, et al.
Frontiers in Nutrition|July 30, 2019
A Novel Amino Acid Composition Ameliorates Short-Term Muscle Disuse Atrophy in Healthy Young MenTanya M Holloway, Chris McGlory, Sean McKellar, et al.
Diabetes, Obesity & Metabolism|August 5, 2025
Efficacy and safety of CT-868, a novel, fully biased, dual glucagon-like peptide-1/glucose-dependent insulinotropic polypeptide receptor agonist, in type 2 diabetes: A double-blind, randomized placebo controlled phase 2 trialManu V Chakravarthy, Michael A Elliott, Luis Acosta, et al.
Cell Reports. Medicine|June 3, 2025
Biased agonism of GLP-1R and GIPR enhances glucose lowering and weight loss, with dual GLP-1R/GIPR biased agonism yielding greater efficacyRuben Rodriguez, Anne Hergarden, Shyam Krishnan, et al.
Molecular Metabolism|November 30, 2025
Effects of CT-388, a once-weekly signaling-biased dual GLP-1/GIP receptor agonist, on weight loss and glycemic control in preclinical models and participants with obesityManu V Chakravarthy, Ruben Rodriguez, Anne Hergarden, et al.
Pageof 3